Jo A. Tucker

839 total citations
26 papers, 645 citations indexed

About

Jo A. Tucker is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jo A. Tucker has authored 26 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jo A. Tucker's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and vaccines and immunoinformatics approaches (5 papers). Jo A. Tucker is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and vaccines and immunoinformatics approaches (5 papers). Jo A. Tucker collaborates with scholars based in United States, Hong Kong and Germany. Jo A. Tucker's co-authors include Edward L. Nelson, Szu‐Wen Wang, Caroline Jochéms, Jeffrey Schlom, N Molino, James L. Gulley, Ravi A. Madan, Kwong Y. Tsang, David J. Liewehr and Seth M. Steinberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Jo A. Tucker

26 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo A. Tucker United States 12 362 328 217 116 70 26 645
Valeria Milani Germany 12 286 0.8× 149 0.5× 419 1.9× 72 0.6× 116 1.7× 28 762
Thanh Tung Tran Vietnam 11 222 0.6× 234 0.7× 132 0.6× 39 0.3× 36 0.5× 26 599
Krishan D. Chhiba United States 10 194 0.5× 77 0.2× 315 1.5× 104 0.9× 19 0.3× 16 844
M Indrová Czechia 16 588 1.6× 292 0.9× 281 1.3× 32 0.3× 19 0.3× 75 840
Shantan Reddy United States 12 91 0.3× 386 1.2× 299 1.4× 53 0.5× 116 1.7× 16 709
Rui Zhu China 16 520 1.4× 114 0.3× 93 0.4× 66 0.6× 10 0.1× 34 747
Joerg Willers Switzerland 6 348 1.0× 47 0.1× 115 0.5× 30 0.3× 29 0.4× 7 537
Faezzah Baharom Sweden 14 480 1.3× 180 0.5× 228 1.1× 66 0.6× 66 0.9× 18 686
Firas Hamdan Finland 11 171 0.5× 216 0.7× 160 0.7× 39 0.3× 92 1.3× 20 453
Murrium Ahmad United Kingdom 13 244 0.7× 148 0.5× 141 0.6× 22 0.2× 22 0.3× 19 419

Countries citing papers authored by Jo A. Tucker

Since Specialization
Citations

This map shows the geographic impact of Jo A. Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo A. Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo A. Tucker more than expected).

Fields of papers citing papers by Jo A. Tucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo A. Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo A. Tucker. The network helps show where Jo A. Tucker may publish in the future.

Co-authorship network of co-authors of Jo A. Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of Jo A. Tucker. A scholar is included among the top collaborators of Jo A. Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo A. Tucker. Jo A. Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tucker, Jo A., et al.. (2023). 1137 MHC Class II peptide on a nanoparticle cancer vaccine induces anti-tumor immune responses. SHILAP Revista de lepidopterología. A1251–A1251. 1 indexed citations
2.
Loukinov, Dmitri, Amanda L. Anderson, Mikayel Mkrtichyan, et al.. (2023). A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors. International Journal of Molecular Sciences. 24(6). 5976–5976. 3 indexed citations
3.
Tucker, Jo A., et al.. (2023). Evaluating Anti-tumor Immune Responses of Protein Nanoparticle-Based Cancer Vaccines. Methods in molecular biology. 2671. 321–333. 3 indexed citations
4.
Tucker, Jo A., et al.. (2022). Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display. Biomaterials Science. 11(2). 596–610. 8 indexed citations
5.
Tucker, Jo A., Edward L. Nelson, Zeev N. Kain, et al.. (2022). Immunological and psychosocial functioning in parents of children with cancer. Supportive Care in Cancer. 30(4). 3379–3388. 6 indexed citations
6.
Tucker, Jo A., et al.. (2022). Macromolecular assembly of bioluminescent protein nanoparticles for enhanced imaging. Materials Today Bio. 17. 100455–100455. 5 indexed citations
7.
Tucker, Jo A., Kathryn Osann, Susie Hsieh, et al.. (2021). Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population. International Journal of Behavioral Medicine. 28(1). 140–150. 8 indexed citations
8.
Osann, Kathryn, Justin Wilford, Lari Wenzel, et al.. (2019). Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial. Supportive Care in Cancer. 27(9). 3301–3310. 3 indexed citations
9.
10.
Molino, N, et al.. (2017). Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells. ACS Biomaterials Science & Engineering. 3(4). 496–501. 31 indexed citations
11.
Tucker, Jo A., et al.. (2017). Construction of a Deep Cutoff Wall along the Mississippi River at East Alton, IL. 249–258. 1 indexed citations
12.
Iyer, Neel S., Kathryn Osann, Susie Hsieh, et al.. (2016). Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life. Clinical Therapeutics. 38(3). 467–475. 28 indexed citations
13.
Molino, N, et al.. (2016). Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses. Biomaterials. 86. 83–91. 80 indexed citations
14.
Jochéms, Caroline, Jo A. Tucker, Kwong-Yok Tsang, et al.. (2014). A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates. Cancer Immunology Immunotherapy. 63(4). 407–418. 78 indexed citations
15.
Tucker, Jo A., Caroline Jochéms, Benjamin Boyerinas, et al.. (2014). Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis. Cancer Immunology Immunotherapy. 63(12). 1307–1317. 19 indexed citations
16.
Farsaci, Benedetto, Caroline Jochéms, Italia Grenga, et al.. (2014). Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets. International Journal of Cancer. 135(4). 862–870. 4 indexed citations
17.
Gulley, James L., Ravi A. Madan, Kwong Y. Tsang, et al.. (2013). Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer. Cancer Immunology Research. 2(2). 133–141. 101 indexed citations
18.
Bilušić, Marijo, Christopher R. Heery, Philip M. Arlen, et al.. (2013). Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma. Cancer Immunology Immunotherapy. 63(3). 225–234. 78 indexed citations
19.
Huen, Ngar‐Yee, Alan Lap‐Yin Pang, Jo A. Tucker, et al.. (2013). Up‐regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration‐resistant prostate cancer. International Journal of Cancer. 133(2). 373–382. 34 indexed citations
20.
Madan, Ravi A., Kwong-Yok Tsang, Marijo Bilušić, et al.. (2013). Effect of Talactoferrin Alfa on the Immune System in Adults With Non-Small Cell Lung Cancer. The Oncologist. 18(7). 821–822. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026